Explore the October 2023 edition of the DCRC Newsletter to discover the latest insights and updates.
Cancer, aging, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may revolutionize treatments.
Tanwi Vartak, PhD Candidate, UCD Conway Institute, presents her personal video ‘My Day as Researcher’ compiled as part of the TY Student Outreach Programme
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Conducting research on what has been a stop-start basis
Prof Catherine Godson, Director, UCD Diabetes Complications Research Centre comments
Pro- resolving lipid mediators: regulators of inflammation, metabolism and kidney function
UCD DCRC Researchers take part in exciting public engagement activity with transition year students
Quinoxaline-containing Lipoxin-A4 mimetics: novel regulators of inflammation
Mechanisms underpinning reductions in diabetic renal injury following intentional weight loss presented at May 2021 EDNSG meeting
Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity